Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) on infarct size in anterior STEMI: PiCSO in ACS study.
Egred M, Bagnall A, Spyridopoulos I, Purcell IF, Das R, Palmer N, Grech ED, Jain A, Stone GW, Nijveldt R, McAndrew T, Zaman A. Egred M, et al. Among authors: nijveldt r. Int J Cardiol Heart Vasc. 2020 May 15;28:100526. doi: 10.1016/j.ijcha.2020.100526. eCollection 2020 Jun. Int J Cardiol Heart Vasc. 2020. PMID: 32435689 Free PMC article.
Pressure-controlled intermittent coronary sinus occlusion (PICSO) in acute ST-segment elevation myocardial infarction: results of the Prepare RAMSES safety and feasibility study.
van de Hoef TP, Nijveldt R, van der Ent M, Neunteufl T, Meuwissen M, Khattab A, Berger R, Kuijt WJ, Wykrzykowska J, Tijssen JG, van Rossum AC, Stone GW, Piek JJ. van de Hoef TP, et al. Among authors: nijveldt r. EuroIntervention. 2015 May;11(1):37-44. doi: 10.4244/EIJY15M03_10. EuroIntervention. 2015. PMID: 25868741 Free article. Clinical Trial.
No benefit of additional treatment with exenatide in patients with an acute myocardial infarction.
Roos ST, Timmers L, Biesbroek PS, Nijveldt R, Kamp O, van Rossum AC, van Hout GP, Stella PR, Doevendans PA, Knaapen P, Velthuis BK, van Royen N, Voskuil M, Nap A, Appelman Y. Roos ST, et al. Among authors: nijveldt r. Int J Cardiol. 2016 Oct 1;220:809-14. doi: 10.1016/j.ijcard.2016.06.283. Epub 2016 Jun 29. Int J Cardiol. 2016. PMID: 27394978 Free article. Clinical Trial.
Transient ST-elevation myocardial infarction versus persistent ST-elevation myocardial infarction. An appraisal of patient characteristics and functional outcome.
Janssens GN, Lemkes JS, van der Hoeven NW, van Leeuwen MAH, Everaars H, van de Ven PM, Brinckman SL, Timmer JR, Meuwissen M, Meijers JCM, van der Weerdt AP, Ten Cate TJF, Piek JJ, von Birgelen C, Diletti R, Escaned J, van Rossum AC, Nijveldt R, van Royen N. Janssens GN, et al. Among authors: nijveldt r. Int J Cardiol. 2021 Aug 1;336:22-28. doi: 10.1016/j.ijcard.2021.05.018. Epub 2021 May 15. Int J Cardiol. 2021. PMID: 34004231 Free article.
Rationale and Design of the Groningen Intervention Study for the Preservation of Cardiac Function with Sodium Thiosulfate after St-segment Elevation Myocardial Infarction (GIPS-IV) trial.
de Koning ML, van Dorp P, Assa S, Hartman MH, Voskuil M, Anthonio RL, Veen D, Pundziute-Do Prado G, Leiner T, van Goor H, van der Meer P, van Veldhuisen DJ, Nijveldt R, Lipsic E, van der Harst P. de Koning ML, et al. Among authors: nijveldt r. Am Heart J. 2022 Jan;243:167-176. doi: 10.1016/j.ahj.2021.08.012. Epub 2021 Sep 15. Am Heart J. 2022. PMID: 34534493 Free article. Clinical Trial.
Early detection of obstructive coronary artery disease in the asymptomatic high-risk population: objectives and study design of the EARLY-SYNERGY trial.
Ties D, van Dorp P, Pundziute G, van der Aalst CM, Gratama JWC, Braam RL, Kuijpers D, Lubbers DD, van der Bilt IAC, Westenbrink BD, Wolcherink MJO, Doggen CJM, Išgum I, Nijveldt R, de Koning HJ, Vliegenthart R, Oudkerk M, van der Harst P. Ties D, et al. Among authors: nijveldt r. Am Heart J. 2022 Apr;246:166-177. doi: 10.1016/j.ahj.2022.01.005. Epub 2022 Jan 14. Am Heart J. 2022. PMID: 35038412 Free article. Clinical Trial.
Timing of revascularization in patients with transient ST-segment elevation myocardial infarction: a randomized clinical trial.
Lemkes JS, Janssens GN, van der Hoeven NW, van de Ven PM, Marques KMJ, Nap A, van Leeuwen MAH, Appelman YEA, Knaapen P, Verouden NJW, Allaart CP, Brinckman SL, Saraber CE, Plomp KJ, Timmer JR, Kedhi E, Hermanides RS, Meuwissen M, Schaap J, van der Weerdt AP, van Rossum AC, Nijveldt R, van Royen N. Lemkes JS, et al. Among authors: nijveldt r. Eur Heart J. 2019 Jan 14;40(3):283-291. doi: 10.1093/eurheartj/ehy651. Eur Heart J. 2019. PMID: 30371767
Temporal Changes in Coronary Hyperemic and Resting Hemodynamic Indices in Nonculprit Vessels of Patients With ST-Segment Elevation Myocardial Infarction.
van der Hoeven NW, Janssens GN, de Waard GA, Everaars H, Broyd CJ, Beijnink CWH, van de Ven PM, Nijveldt R, Cook CM, Petraco R, Ten Cate T, von Birgelen C, Escaned J, Davies JE, van Leeuwen MAH, van Royen N. van der Hoeven NW, et al. Among authors: nijveldt r. JAMA Cardiol. 2019 Aug 1;4(8):736-744. doi: 10.1001/jamacardio.2019.2138. JAMA Cardiol. 2019. PMID: 31268466 Free PMC article. Clinical Trial.
Beta-blocker effect on ST-segment: a prespecified analysis of the EARLY-BAMI randomised trial.
Fabris E, Hermanides R, Roolvink V, Ibanez B, Ottervanger JP, Pizarro G, van Royen N, Mateos-Rodriguez A, Dambrink JH, Albarran A, Fernández-Avilés F, Botas J, Remkes W, Hernandez-Jaras V, Kedhi E, Zamorano J, Alfonso F, García-Lledó A, van Leeuwen M, Nijveldt R, Postma S, Kolkman E, Gosselink M, de Smet B, Rasoul S, Lipsic E, Piek JJ, Fuster V, van 't Hof AW. Fabris E, et al. Among authors: nijveldt r. Open Heart. 2020 Dec;7(2):e001316. doi: 10.1136/openhrt-2020-001316. Open Heart. 2020. PMID: 33318150 Free PMC article. Clinical Trial.
274 results